Skip to main content

Madonna at the Golden Globes, Jan. 15, 2012 in Beverly Hills, Calif.

Lucy Nicholson / Reuters

Deadmau5 and Madonna have declared a truce on Twitter after the Canadian electronic DJ slagged the Material Girl for making comments that he interpreted as glamorization of drug use.

The 53-year-old pop star's new album is titled MDNA, which some have assumed is a reference to MDMA, also known as the drug ecstasy.

Deadmau5 also called out Madonna for a comment at the recent Ultra Music Festival in Miami, when she asked the crowd: "How many people in this crowd have seen Molly?"

Story continues below advertisement

Molly is a slang term for ecstasy.

The DJ from Niagara Falls, Ont., used his Facebook, Twitter and Tumblr blog accounts to slam Madonna with expletive-filled rants condemning her behaviour. He wrote a long blog post insisting that electronic music should no longer be closely tied to drug culture.

Rather than punching back, Madonna responded by simply tweeting "lovemau5" and an old photo of her wearing Minnie Mouse-style ears — similar to what Deadmau5 wears while performing.

Text added to the photo reads: "From one mouse to another. I don't support drug use and I never have. I was referring to the song called Have you Seen Molly written by my friend Cedric Gervais who I almost worked with on my album."

That explanation seemed to have appeased the four-time Juno winner, whose real name is Joel Zimmerman.

"Fair enough, I was just voicing my concerns as I usually do. +1 respect for clearing it up personally," he tweeted to her.

"Communication is always best," reads a response from Madonna's Twitter account. "You should have called me first, we could have cleared it up 'privately.' ) See you on the road."

Story continues below advertisement

Deadmau5 added that he considers the feud over.

"Well there you have it kids. I've said what I needed to say, which I'll still stand by, and so did she. Life goes on. No more talk of that."

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter